Patient selection for proton therapy in lung cancer: Updating and internal-external cross-validation of a normal tissue complication probability model for acute oesophageal toxicity.
PURPOSE To externally validate and update a published normal tissue complication probability (NTCP) model for the prediction of Grade ≥ 2 acute oesophageal toxicity (AOT) in lung cancer patients receiving (chemo-)radiotherapy (predictors: concurrent chemotherapy, gender, tumour stage, mean oesophagus dose (MOD)). MET...